{
 "drug": "Carbamazepine Capsule, Extended Release",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "12/19/2025",
 "dayN": 249,
 "cat": "Neurology",
 "companies": [
  "Takeda Pharmaceuticals USA Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "12/19/2025",
   "update_type": "New",
   "initial_posting_date": "12/19/2025",
   "package_ndc": "54092-171-12",
   "generic_name": "Carbamazepine Capsule, Extended Release",
   "contact_info": "855-268-1825",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA020712"
    ],
    "brand_name": [
     "CARBATROL"
    ],
    "generic_name": [
     "CARBAMAZEPINE"
    ],
    "manufacturer_name": [
     "Takeda Pharmaceuticals America, Inc."
    ],
    "product_ndc": [
     "54092-171",
     "54092-172",
     "54092-173"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "CARBAMAZEPINE"
    ],
    "rxcui": [
     "200131",
     "200133",
     "308977",
     "313931",
     "388311",
     "404742"
    ],
    "spl_id": [
     "39171a32-c78d-4130-be53-638e19cf2261"
    ],
    "spl_set_id": [
     "bc03e499-5bac-4293-bff4-6864153a624d"
    ],
    "package_ndc": [
     "54092-171-12",
     "54092-172-12",
     "54092-173-12"
    ],
    "nui": [
     "N0000008486",
     "N0000175751",
     "N0000185506",
     "N0000191266",
     "N0000187064",
     "N0000185507",
     "N0000185607"
    ],
    "pharm_class_pe": [
     "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_epc": [
     "Mood Stabilizer [EPC]"
    ],
    "pharm_class_moa": [
     "Cytochrome P450 3A4 Inducers [MoA]",
     "Cytochrome P450 1A2 Inducers [MoA]",
     "Cytochrome P450 2B6 Inducers [MoA]",
     "Cytochrome P450 2C9 Inducers [MoA]",
     "Cytochrome P450 2C19 Inducers [MoA]"
    ],
    "unii": [
     "33CM23913M"
    ]
   },
   "update_date": "12/19/2025",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Capsule, Extended Release",
   "presentation": "Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12)",
   "company_name": "Takeda Pharmaceuticals USA Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "12/19/2025",
   "update_type": "New",
   "initial_posting_date": "12/19/2025",
   "package_ndc": "54092-172-12",
   "generic_name": "Carbamazepine Capsule, Extended Release",
   "contact_info": "855-268-1825",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA020712"
    ],
    "brand_name": [
     "CARBATROL"
    ],
    "generic_name": [
     "CARBAMAZEPINE"
    ],
    "manufacturer_name": [
     "Takeda Pharmaceuticals America, Inc."
    ],
    "product_ndc": [
     "54092-172",
     "54092-171",
     "54092-173"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "CARBAMAZEPINE"
    ],
    "rxcui": [
     "200131",
     "200133",
     "308977",
     "313931",
     "388311",
     "404742"
    ],
    "spl_id": [
     "39171a32-c78d-4130-be53-638e19cf2261"
    ],
    "spl_set_id": [
     "bc03e499-5bac-4293-bff4-6864153a624d"
    ],
    "package_ndc": [
     "54092-171-12",
     "54092-172-12",
     "54092-173-12"
    ],
    "nui": [
     "N0000008486",
     "N0000175751",
     "N0000185506",
     "N0000191266",
     "N0000187064",
     "N0000185507",
     "N0000185607"
    ],
    "pharm_class_pe": [
     "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_epc": [
     "Mood Stabilizer [EPC]"
    ],
    "pharm_class_moa": [
     "Cytochrome P450 3A4 Inducers [MoA]",
     "Cytochrome P450 1A2 Inducers [MoA]",
     "Cytochrome P450 2B6 Inducers [MoA]",
     "Cytochrome P450 2C9 Inducers [MoA]",
     "Cytochrome P450 2C19 Inducers [MoA]"
    ],
    "unii": [
     "33CM23913M"
    ]
   },
   "update_date": "12/19/2025",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Capsule, Extended Release",
   "presentation": "Carbatrol, Capsule, Extended Release, 200 mg (NDC 54092-172-12)",
   "company_name": "Takeda Pharmaceuticals USA Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "12/19/2025",
   "update_type": "New",
   "initial_posting_date": "12/19/2025",
   "package_ndc": "54092-173-12",
   "generic_name": "Carbamazepine Capsule, Extended Release",
   "contact_info": "855-268-1825",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA020712"
    ],
    "brand_name": [
     "CARBATROL"
    ],
    "generic_name": [
     "CARBAMAZEPINE"
    ],
    "manufacturer_name": [
     "Takeda Pharmaceuticals America, Inc."
    ],
    "product_ndc": [
     "54092-173",
     "54092-171",
     "54092-172"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "CARBAMAZEPINE"
    ],
    "rxcui": [
     "200131",
     "200133",
     "308977",
     "313931",
     "388311",
     "404742"
    ],
    "spl_id": [
     "39171a32-c78d-4130-be53-638e19cf2261"
    ],
    "spl_set_id": [
     "bc03e499-5bac-4293-bff4-6864153a624d"
    ],
    "package_ndc": [
     "54092-171-12",
     "54092-172-12",
     "54092-173-12"
    ],
    "nui": [
     "N0000008486",
     "N0000175751",
     "N0000185506",
     "N0000191266",
     "N0000187064",
     "N0000185507",
     "N0000185607"
    ],
    "pharm_class_pe": [
     "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_epc": [
     "Mood Stabilizer [EPC]"
    ],
    "pharm_class_moa": [
     "Cytochrome P450 3A4 Inducers [MoA]",
     "Cytochrome P450 1A2 Inducers [MoA]",
     "Cytochrome P450 2B6 Inducers [MoA]",
     "Cytochrome P450 2C9 Inducers [MoA]",
     "Cytochrome P450 2C19 Inducers [MoA]"
    ],
    "unii": [
     "33CM23913M"
    ]
   },
   "update_date": "12/19/2025",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Capsule, Extended Release",
   "presentation": "Carbatrol, Capsule, Extended Release, 300 mg (NDC 54092-173-12)",
   "company_name": "Takeda Pharmaceuticals USA Inc.",
   "status": "To Be Discontinued"
  }
 ]
}